China National Biotec Group Company Limited
China National Biotec Group Company Limited (CNBG), headquartered in Beijing, China, is a leading player in the biopharmaceutical industry. Founded in 1998, CNBG has established itself as a pioneer in vaccine development, blood products, and diagnostic reagents, serving both domestic and international markets. With a robust presence across various regions in China and a growing footprint globally, CNBG is renowned for its innovative approach to biotechnology. The company’s core offerings include a diverse range of vaccines and biopharmaceuticals, distinguished by their high efficacy and safety profiles. As a subsidiary of China National Pharmaceutical Group Corporation (Sinopharm), CNBG has achieved significant milestones, including the development of several key vaccines that have contributed to public health initiatives. Its commitment to research and development positions CNBG as a formidable entity in the global biopharmaceutical landscape.
DitchCarbon Score
How does China National Biotec Group Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China National Biotec Group Company Limited's score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
China National Biotec Group Company Limited's reported carbon emissions
China National Biotec Group Company Limited currently does not have publicly available carbon emissions data or specific reduction targets. As a leading entity in the biotechnology sector, the company is expected to align with industry standards for climate commitments. However, without concrete emissions figures or defined reduction initiatives, it is unclear how they are addressing their carbon footprint. The absence of data highlights a potential area for improvement in transparency regarding their environmental impact and climate strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China National Biotec Group Company Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
